GW RhythmX Software Now Available on Microsoft Marketplace
GW RhythmX has launched its RhythmX Pulse software on the Microsoft Marketplace. The solution assists clinicians in making real-time, patient-specific decisions based on comprehensive data.
Palo Alto, Calif. – GW RhythmX announced on July 15, 2026, that its RhythmX Pulse software is now available on the Microsoft Marketplace. This expands the software's reach to Microsoft customers worldwide, who can now discover and deploy an integrated solution across Microsoft Azure and other Microsoft products.
RhythmX Pulse utilizes Dragon Copilot technology to analyze patient encounters in real time. It compares this encounter data with a patient's comprehensive history, including medical records, current medications, clinical guidelines, social context, and payer and formulary rules. Based on this analysis, the software provides clinicians with actionable, patient-specific recommendations before the visit concludes.
The recommendations can include suggestions for documentation improvement, alerts for care gaps, coding opportunities, guideline-based treatment options, and formulary-aware medication alternatives, all supported by evidence. Clinicians retain control, with the ability to accept, edit, or dismiss each recommendation.
Health systems already using Dragon Copilot can now add RhythmX Pulse directly through the Microsoft Marketplace, eliminating the need for separate implementation. GW RhythmX stated this is the first phase of a broader roadmap with Microsoft, with future capabilities planned to extend across the entire care journey.
GW RhythmX, a SymphonyAI Group company, focuses on AI-powered precision care and patient engagement. The company's solutions are already deployed in over 150 health systems and reach millions of patients.